L39 Capital
  • Home
  • AI Biotech Fund
  • About
    • Performance
    • Team
  • Our Approach
    • Our Philosophy
  • Investment Process
  • Our Investments
  • Invest Now
  • Contact
Picture

Mark Garkawe


​Mark is a founding director of the Manager. He was responsible for establishing the Fund, and is currently responsible for day to day trading, in-house administration and liaising with other stakeholders, including Sargon Corporate Trustees Ltd (the Custodian of the Fund) and Primary Securities Ltd (the holder of AFS Licence 224107).

Mark is also a founding director in 3555 Capital, a wealth advisory business assisting retired SMSF Trustees in portfolio construction and asset allocation. Mark holds a Bachelor of Economics and an Advanced Diploma in Financial Planning.
​
​E: [email protected]
T:  +61 415 634 468
E:  [email protected]
Level 1, Suit 7
321 Chapel Street
Prahran, Victoria, 3181
​Australia
© COPYRIGHT 2022 L39 Capital | ABN 94 614 364 117
L39 Capital Pty Ltd (L39) ABN 94 614 364 117 is a Corporate Authorised Representative (CAR #1250323) of Primary Securities Ltd (Primary) ABN 96 089 812 635 AFSL 224107. Primary is the trustee of the L39 Capital fund. L39 is authorised to provide general advice only to wholesale investors. This website is for general informational purposed only and no person(s) circumstances, objectives or needs have been taken into account when preparing this information.
  • Home
  • AI Biotech Fund
  • About
    • Performance
    • Team
  • Our Approach
    • Our Philosophy
  • Investment Process
  • Our Investments
  • Invest Now
  • Contact